Related Experiment Video
Updated: Jul 6, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Emerging drugs for malignant glioma
1Princess Margaret Hospital, Department of Medicine, 610 University Avenue, Suite 18-717, Toronto, Ontario, M5G 2M9, Canada. warren.mason@uhn.on.ca
Expert Opinion on Emerging Drugs
|March 7, 2008
Summary
Targeted therapies for malignant glioma have shown disappointing results, with limited activity despite good tolerability. New treatments are needed to improve survival for glioblastoma multiforme (GBM) patients.
Area of Science:
- Neuro-oncology
- Cancer Therapeutics
- Drug Development
Background:
- Malignant gliomas, particularly glioblastoma multiforme (GBM), represent aggressive brain tumors with poor prognoses.
- Current standard treatment involves surgery, radiotherapy, and temozolomide chemotherapy, offering limited survival benefits.
- Advances in GBM treatment necessitate the development of novel, targeted therapeutic strategies.
Purpose of the Study:
- To review the recent clinical experience with targeted therapeutics for malignant glioma.
- To evaluate the efficacy and safety of emerging targeted agents in treating malignant gliomas.
Main Methods:
- A Medline literature search was conducted for studies published between 2000 and the present.
- Key studies focusing on targeted therapies for malignant glioma were identified and summarized.
Main Results:
- Experience with targeted therapeutics for malignant glioma to date has been largely disappointing.
- While generally well-tolerated, these agents have demonstrated limited clinical activity against malignant gliomas.
- No significant improvements in patient survival have been attributed to current targeted therapies.
Conclusions:
- Novel therapeutics with demonstrable activity against malignant gliomas are urgently required.
- Improved treatment strategies are essential to enhance the prognosis for patients diagnosed with these devastating brain cancers.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...